Pharmaceutical Science Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About the Journal
    • Publisher
    • Aim and Scope
    • Ownership & Management
    • Indexing and Abstracting
    • Editorial Team
    • Privacy Statement
    • Journal History
  • Issues
    • Current
    • Archives
  • For Authors
    • Author Guidelines
    • Types of articles
    • Templates
    • Publication Fees
    • Peer Review Process
  • For Reviewers
    • Reviewers' Guidelines
    • Responcibility for Reviewres
  • Publication Ethics
    • Publication Ethics and Malpractice Statement
    • Code of Publishing Ethics
  • Policies and Process
    • Allegations of Misconduct
    • Article Processing Charge (APC)
    • Advertisement and Marketing
    • Archiving
    • Article Withdrawal & Retraction Policy
    • Conflict of Interest
    • Copyright Notice
    • Complaints Policy
    • Editorial Policies
    • Open Access Policy
    • Peer-Review Policy
    • Post- Publication Discussions and Corrections Policy
    • Principles of Transparency
    • Publication Policy
    • Repository
    • Using Artificial Intelligence (AI) Plicies
  • New Submission
  • FAQ
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

March 2018

Synthesis and Biological Activity Evaluations of Novel Heterobimetallic Platinum(II)–Gold(I) Complexes as Bio-imaging Agents.

  • Mahsa Pooranian
  • Maryam Haydari
  • Hamid R shahsavari
  • Masood Fereidoonnezhad

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 March 2018 , Page 58-59
https://doi.org/10.22037/ipa.v1i1.20057 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Platinum-based drugs have become a mainstay of cancer therapy, approximately half of all patients undergoing chemotherapeutic treatment receive a platinum drug. Despite the pervasiveness of platinum drugs in cancer treatment regimens, a number of attendant disadvantages such as resistance to some cancer types and side effects exist. Gold complexes are also emerging as a new class of metal complexes with outstanding cytotoxic properties and are presently being evaluated as potential antitumor agents.

Methods and Results: Here, some novel heterobimetallic platinum(II)–gold(I) complexes were synthesized and their cytotoxic activities against different human cancer cell lines such as A549 (human lung cancer),

SKOV3 (human ovarian cancer) and MDA-MB-231 (human breast cancer) were evaluated. Electrophoresis mobility shift assay and molecular modeling investigations have been performed to determine the specific binding mode or the binding orientation of these compounds to DNA. Molecular docking studies of them on DNA were performed by means of AutoDock 4.2. Fluorescence emission properties of them were assessed using fluorescent microscopy imaging.

In comparison to cis-platin, these compounds displayed significantly higher in vitro cytotoxicity on the studied cell lines. They enter SKOV3 cells rapidly, retaining their phosphorescence and localise simultaneously in cytoplasm, especially in perinuclear regions. So they are suitable candidates for time resolved emission imaging microscopy (TREM). Electrophoresis mobility shift assay showed a little shift and little interaction with plasmid DNA, though this shift is not as much as cis-platin. They may exert their cytotoxic effect through a different mechanism.

Conclusions: According to the results, careful drug design would result in producing potential antitumor agents with high efficacy. These Pt(II)-Au(I) complexes can be used in biological labelling and cellular imaging studies, due to desirable absorption and emission of them in solution under ambient conditions. Hence, they had a potential value for drug development as anticancer agents.

Keywords:
  • Bio-imaging; Cytotoxic activity, Platinum(II)–Gold(I) complexes,  DNA binding,  Molecular docking
  • PDF

How to Cite

Pooranian, M., Haydari, M., R shahsavari, H., & Fereidoonnezhad, M. (2018). Synthesis and Biological Activity Evaluations of Novel Heterobimetallic Platinum(II)–Gold(I) Complexes as Bio-imaging Agents. International Pharmacy Acta, 1(1), 58–59. https://doi.org/10.22037/ipa.v1i1.20057
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 281 times
  • PDF Downloaded: 189 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus